Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2015-04-24

EMA recommends avoidance of certain hepatitis C medicines and amiodarone together

View source ↗

Summary

EMA recommends avoiding concurrent use of certain hepatitis C medicines with amiodarone due to potential risk of severe bradycardia or heart block.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amiodarone (amiodarone)
  • hepatitis C medicines (specific agents not named in prompt)